Form 4: BullFrog AI Director Receives Equity Grants

BullFrog AI Holdings, Inc. Director Jason David Hanson was granted 8,523 shares and restricted stock units under the company's 2022 Equity Compensation Plan.

Summary

• Jason David Hanson, a Director of BullFrog AI Holdings, Inc. (BFRG), reported two equity transactions on August 22, 2025.
• He acquired 5,710 Restricted Stock Units (RSUs) under the company's 2022 Equity Compensation Plan, vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027.
• Forfeiture restrictions on these RSUs will accelerate upon a change in control or a significant financing event.
• Additionally, he received 2,813 shares of Common Stock as an equity grant, which were fully vested upon grant.
• Following these transactions, Mr. Hanson beneficially owns a total of 8,523 shares of Common Stock.

Sentiment

Score: 7

Explanation: The filing reports standard equity compensation for a director, which is generally a positive sign of alignment and commitment. No negative information is present.

Positives

• Director Jason David Hanson received equity grants, aligning his interests with shareholders.
• The grants include fully vested common stock, providing immediate ownership.
• RSU vesting acceleration clauses provide potential upside for the director in case of a change in control or significant financing.

Risks

• The value of the equity grants is tied to the future performance of BullFrog AI Holdings, Inc.'s common stock.
• RSUs are subject to forfeiture if vesting conditions are not met, such as the director leaving the company before the vesting dates.

Future Outlook

The filing indicates future vesting dates for RSUs on September 1, 2026, and September 1, 2027, suggesting a continued commitment from the director. The acceleration clauses for RSUs upon a change in control or significant financing hint at potential future strategic events for the company.

Industry Context

Equity grants to directors are a common practice in the biotechnology and AI sectors, particularly for early-stage or growth companies like BullFrog AI, to attract and retain talent and align interests with long-term company performance.

Comparison to Industry Standards

• Equity compensation for directors is a standard practice across industries, including biotech and AI, to incentivize long-term commitment and performance.
• The vesting schedule for RSUs (50% in 2026, 50% in 2027) is typical for aligning director interests over a multi-year horizon, comparable to practices at companies like Recursion Pharmaceuticals or Insitro, which also use equity to compensate key personnel.
• The inclusion of acceleration clauses for vesting upon a change in control or significant financing is also a common feature in equity plans, particularly in the high-growth tech and biotech sectors, to protect executive and director interests during M&A or large funding rounds.

Corporate Governance

Stakeholder Impact

• Shareholders: Director's interests are further aligned with shareholder value through equity ownership.
• Management: Director's commitment to the company is reinforced.

Next Steps

• Vesting of 50% of RSUs on September 1, 2026.
• Vesting of the remaining 50% of RSUs on September 1, 2027.
• Potential acceleration of RSU vesting upon a change in control or significant financing event.

Key Dates

Recommendation

This Form 4 filing reports routine equity compensation for a director, which is a standard practice to align interests. It does not contain information that would fundamentally alter the investment thesis for BullFrog AI Holdings, Inc., warranting a 'hold' recommendation based solely on this filing. Investors should consider broader company performance and market conditions.

Keywords

BullFrog AI Holdings, BFRG, SEC Form 4, Insider Trading, Equity Grant, Restricted Stock Units, RSUs, Director Compensation, Jason David Hanson